{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:17:47Z","timestamp":1778620667371,"version":"3.51.4"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/INSPIRE\/04\/2016\/000191"],"award-info":[{"award-number":["DST\/INSPIRE\/04\/2016\/000191"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["102\/IFD\/SAN\/1117\/2018-19"],"award-info":[{"award-number":["102\/IFD\/SAN\/1117\/2018-19"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/22\/2016"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/22\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["DDR-IIRP-23-1583"],"award-info":[{"award-number":["DDR-IIRP-23-1583"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nano.2025.102817","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T12:55:38Z","timestamp":1744030538000},"page":"102817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Melanoma immunotherapy by nanosphere-vaccine elicited CD4+ and CD8+ T-cell response for tumor regression"],"prefix":"10.1016","volume":"66","author":[{"given":"Kalpana","family":"Javvaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venugopal","family":"Vangala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh Babu","family":"Sayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu","family":"Maturi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerti","family":"Bhamidipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Brunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3080-7476","authenticated-orcid":false,"given":"Sunil","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagaprasad","family":"Puvvada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.nano.2025.102817_bb0005","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/cancers12071819","article-title":"Sex and gender disparities in melanoma","volume":"12","author":"Bellenghi","year":"2020","journal-title":"Cancers"},{"issue":"10 Suppl","key":"10.1016\/j.nano.2025.102817_bb0010","first-page":"S234","article-title":"Strategies for individualizing management of patients with metastatic melanoma: a managed care perspective","volume":"21","author":"Goldstein","year":"2015","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10198-015-0757-y","article-title":"Economic burden of toxicities associated with treating metastatic melanoma in eight countries","volume":"18","author":"Wehler","year":"2017","journal-title":"Eur J Health Econ"},{"issue":"11","key":"10.1016\/j.nano.2025.102817_bb0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamadermatol.2023.3179","article-title":"Changes in health care costs, survival, and time toxicity in the era of immunotherapy and targeted systemic therapy for melanoma","volume":"159","author":"Bateni","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.nano.2025.102817_bb0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2025.102817_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01148","article-title":"Immune system evasion as hallmark of melanoma progression: the role of dendritic cells","volume":"9","author":"Tucci","year":"2019","journal-title":"Front Oncol"},{"issue":"6673","key":"10.1016\/j.nano.2025.102817_bb0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.nano.2025.102817_bb0040","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1586\/1744666X.2014.955851","article-title":"The immune escape in melanoma: role of the impaired dendritic cell function","volume":"10","author":"Tucci","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"10.1016\/j.nano.2025.102817_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/2326-6066.CIR-20-0785","article-title":"Site-dependent immune escape due to impaired dendritic cell cross-priming","volume":"9","author":"Diamond","year":"2021","journal-title":"Cancer Immunol Res"},{"issue":"19","key":"10.1016\/j.nano.2025.102817_bb0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.21037\/atm.2017.06.13","article-title":"Dendritic cell therapy in melanoma","volume":"5","author":"Alvarez-Dominguez","year":"2017","journal-title":"Annals of Translational Medicine"},{"issue":"4","key":"10.1016\/j.nano.2025.102817_bb0055","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V98.4.1070","article-title":"Cross-presentation of tumor antigens by bone marrow\u2013derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression","volume":"98","author":"Sotomayor","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.nano.2025.102817_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"10.1016\/j.nano.2025.102817_bb0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri1647","article-title":"Tuning immune responses: diversity and adaptation of the immunological synapse","volume":"5","author":"Friedl","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2025.102817_bb0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.20.100301.064828","article-title":"Antigen presentation and T cell stimulation by dendritic cells","volume":"20","author":"Guermonprez","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"5681","key":"10.1016\/j.nano.2025.102817_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.1100369","article-title":"Cancer immunotherapy: a treatment for the masses","volume":"305","author":"Blattman","year":"2004","journal-title":"Science (New York, NY)"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0080","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/mp900311x","article-title":"In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants","volume":"7","author":"Bachelder","year":"2010","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.nano.2025.102817_bb0085","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1046\/j.1365-2958.1999.01272.x","article-title":"Delivery of protein to the cytosol of macrophages using Escherichia coli K-12","volume":"31","author":"Higgins","year":"1999","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molimm.2014.10.020","article-title":"Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein","volume":"64","author":"Basto","year":"2015","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.nano.2025.102817_bb0095","article-title":"Immune response profile induced by combined alum and glycyrrhizin liposomes in Balb\/c mice immunized with ovalbumin, Turkish","volume":"11","author":"Tahvili","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2025.102817_bb0100","doi-asserted-by":"crossref","unstructured":"G. Cui, Y. Sun, L. Qu, C. Shen, Y. Sun, F. Meng, et al., Uplifting Antitumor Immunotherapy with Lymph-Node-Targeted and Ratio-Controlled Codelivery of Tumor Cell Lysate and Adjuvant, Advanced Healthcare Materials (2024) 2303690.","DOI":"10.1002\/adhm.202303690"},{"issue":"7","key":"10.1016\/j.nano.2025.102817_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110189","article-title":"Biomineralization-inspired synthesis of autologous cancer vaccines for personalized metallo-immunotherapy","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/CJI.0b013e31816a8910","article-title":"Adenovirus MART-1\u2013engineered autologous dendritic cell vaccine for metastatic melanoma","volume":"31","author":"Butterfield","year":"2008","journal-title":"J Immunother"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.180.1.35","article-title":"A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"180","author":"Coulie","year":"1994","journal-title":"J Exp Med"},{"issue":"14","key":"10.1016\/j.nano.2025.102817_bb0120","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","article-title":"Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.nano.2025.102817_bb0125","first-page":"2756","article-title":"Phase I trial of a MART-1 peptide vaccine with incomplete Freund\u2019s adjuvant for resected high-risk melanoma","volume":"5","author":"Wang","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.nano.2025.102817_bb0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nano.2010.12.010","article-title":"Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA","volume":"7","author":"Perche","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102817_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2014.11.033","article-title":"In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model","volume":"198","author":"Silva","year":"2015","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.nano.2025.102817_bb0140","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/eji.201142361","article-title":"Nano-particle vaccination combined with TLR-7 and-9 ligands triggers memory and effector CD 8+ T-cell responses in melanoma patients","volume":"42","author":"Goldinger","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2025.102817_bb0145","first-page":"5231","article-title":"Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen","author":"Saluja","year":"2014","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0150","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1038\/srep11760","article-title":"Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression","volume":"5","author":"Puvvada","year":"2015","journal-title":"Sci Rep"},{"issue":"35","key":"10.1016\/j.nano.2025.102817_bb0155","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/18\/35\/355602","article-title":"A new approach to synthesize uniform metal oxide hollow nanospheres via controlled precipitation","volume":"18","author":"Qian","year":"2007","journal-title":"Nanotechnology"},{"issue":"41","key":"10.1016\/j.nano.2025.102817_bb0160","doi-asserted-by":"crossref","first-page":"17455","DOI":"10.1021\/jp105583b","article-title":"ZnO\/ZnFe2O4 magnetic fluorescent bifunctional hollow nanospheres: synthesis, characterization, and their optical\/magnetic properties","volume":"114","author":"Qian","year":"2010","journal-title":"J Phys Chem C"},{"issue":"4","key":"10.1016\/j.nano.2025.102817_bb0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jamia\/ocw004","article-title":"A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients","volume":"23","author":"Cheng","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.nano.2025.102817_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2020.02.015","article-title":"Dendritic cell development in infection","volume":"121","author":"Bieber","year":"2020","journal-title":"Mol Immunol"},{"issue":"26","key":"10.1016\/j.nano.2025.102817_bb0175","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1073\/pnas.1805542115","article-title":"Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1166\/jbn.2016.2141","article-title":"Green synthesis and characterization of monodispersed gold nanoparticles: toxicity study, delivery of doxorubicin and its bio-distribution in mouse model","volume":"12","author":"Mukherjee","year":"2016","journal-title":"J Biomed Nanotechnol"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0185","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1039\/C8BM01272E","article-title":"In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles","volume":"7","author":"Gulla","year":"2019","journal-title":"Biomater Sci"},{"issue":"8","key":"10.1016\/j.nano.2025.102817_bb0190","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/acsmedchemlett.8b00240","article-title":"Carbon dots from sugars and ascorbic acid: role of the precursors on morphology, properties, toxicity, and drug uptake","volume":"9","author":"Cailotto","year":"2018","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"10.1016\/j.nano.2025.102817_bb0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0006-3495(90)82382-1","article-title":"Physical properties of single phospholipid bilayers adsorbed to micro glass beads. A new vesicular model system studied by 2H-nuclear magnetic resonance","volume":"58","author":"Bayerl","year":"1990","journal-title":"Biophys J"},{"issue":"33","key":"10.1016\/j.nano.2025.102817_bb0200","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.biomaterials.2007.05.044","article-title":"Targeted binding of PLA microparticles with lipid-PEG-tethered ligands","volume":"28","author":"Duncanson","year":"2007","journal-title":"Biomaterials"},{"issue":"30","key":"10.1016\/j.nano.2025.102817_bb0205","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1021\/jp027835b","article-title":"The assembly of coated nanocrystals","volume":"107","author":"Liz-Marz\u00e1n","year":"2003","journal-title":"J Phys Chem B"},{"issue":"2","key":"10.1016\/j.nano.2025.102817_bb0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/jcis.1994.1242","article-title":"Interactions of silica surfaces","volume":"165","author":"Vigil","year":"1994","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.nano.2025.102817_bb0215","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.scitotenv.2017.10.076","article-title":"Green synthesized nanoclusters of ultra-small zero valent iron nanoparticles as a novel dye removing material","volume":"621","author":"Ebrahiminezhad","year":"2018","journal-title":"Sci Total Environ"},{"issue":"51","key":"10.1016\/j.nano.2025.102817_bb0220","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/anie.201107817","article-title":"Spherical ordered mesoporous carbon nanoparticles with high porosity for lithium\u2013sulfur batteries","volume":"15","author":"Schuster","year":"2012","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"10.1016\/j.nano.2025.102817_bb0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nmat2992","article-title":"The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers","volume":"10","author":"Ashley","year":"2011","journal-title":"Nat Mater"},{"issue":"7","key":"10.1016\/j.nano.2025.102817_bb0230","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/nl100991w","article-title":"Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake","volume":"10","author":"Cauda","year":"2010","journal-title":"Nano Lett"},{"issue":"22","key":"10.1016\/j.nano.2025.102817_bb0235","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1021\/ja902039y","article-title":"Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery","volume":"131","author":"Liu","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.nano.2025.102817_bb0240","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1021\/ja808018y","article-title":"Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles","volume":"131","author":"Liu","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"9","key":"10.1016\/j.nano.2025.102817_bb0245","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1021\/nn9005413","article-title":"A membrane-reconstituted multisubunit functional proton pump on mesoporous silica particles","volume":"3","author":"Nordlund","year":"2009","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/adhm.201100033","article-title":"Cascaded photoinduced drug delivery to cells from multifunctional core-shell mesoporous silica","volume":"1","author":"Schlossbauer","year":"2012","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"10.1016\/j.nano.2025.102817_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2025.102817_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-8-4","article-title":"Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies","volume":"8","author":"Jin","year":"2010","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.nano.2025.102817_bb0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/acs.bioconjchem.8b00799","article-title":"Endosomal escape and cytosolic penetration of macromolecules mediated by synthetic delivery agents","volume":"30","author":"Brock","year":"2018","journal-title":"Bioconjug Chem"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100534","article-title":"Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity","volume":"3","author":"Bikorimana","year":"2022","journal-title":"Cell Reports Medicine"},{"key":"10.1016\/j.nano.2025.102817_bb0275","series-title":"Interleukin 4","author":"Smiley","year":"1998"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0280","first-page":"377","article-title":"IL17A and IL17F genetic variations in iranian patients with urothelial bladder cancer: a case-control study","volume":"12","author":"Aslani","year":"2021","journal-title":"Middle East Journal of Cancer"},{"issue":"3","key":"10.1016\/j.nano.2025.102817_bb0285","first-page":"1059","article-title":"A prognostic impact of interleukin 17 (IL-17) as an immune-marker in patients with bladder cancer","volume":"77","author":"Shakir","year":"2022","journal-title":"Archives of Razi Institute"},{"issue":"4","key":"10.1016\/j.nano.2025.102817_bb0290","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12441","article-title":"Anti-cancer therapy with TNF \u03b1 and IFN \u03b3: a comprehensive review","volume":"51","author":"Shen","year":"2018","journal-title":"Cell Prolif"},{"issue":"4","key":"10.1016\/j.nano.2025.102817_bb0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/toxins13040288","article-title":"Cytotoxic effects and intracellular localization of Bin toxin from Lysinibacillus sphaericus in human liver cancer cell line","volume":"13","author":"Kanwal","year":"2021","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0300","first-page":"1","article-title":"The plant defensin NaD1 induces tumor cell death via a non-apoptotic, membranolytic process","volume":"3","author":"Baxter","year":"2017","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.nano.2025.102817_bb0305","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1172\/JCI42002","article-title":"Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma","volume":"120","author":"Eyles","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0310","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.180.1.130","article-title":"Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases","volume":"180","author":"Lengagne","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.nano.2025.102817_bb0315","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/imr.12657","article-title":"The function and dysfunction of memory cd 8+ T cells in tumor immunity","volume":"283","author":"Reading","year":"2018","journal-title":"Immunol Rev"},{"issue":"25","key":"10.1016\/j.nano.2025.102817_bb0320","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nano.2025.102817_bb0325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.nano.2025.102817_bb0330","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/pcmr.12933","article-title":"Strategies in DNA vaccine for melanoma cancer","volume":"34","author":"Rezaei","year":"2021","journal-title":"Pigm Cell Melanoma Res"},{"issue":"13","key":"10.1016\/j.nano.2025.102817_bb0335","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/1078-0432.CCR-14-3073","article-title":"Characterization of PD-L1 expression and associated T-cell infiltrates in metastatic melanoma samples from variable anatomic sites","volume":"21","author":"Kluger","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2025.102817_bb0340","series-title":"Molecular Diagnostics for Melanoma: Methods and Protocols","first-page":"287","article-title":"Tumor-infiltrating lymphocytes and their significance in melanoma prognosis","author":"Schatton","year":"2014"},{"issue":"8","key":"10.1016\/j.nano.2025.102817_bb0345","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/2326-6066.CIR-15-0143","article-title":"Reflections on the histopathology of tumor-infiltrating lymphocytes in melanoma and the host immune response","volume":"3","author":"Mihm","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"24","key":"10.1016\/j.nano.2025.102817_bb0350","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.nano.2025.102817_bb0355","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/s41379-021-00870-2","article-title":"Histological regression in melanoma: impact on sentinel lymph node status and survival","volume":"34","author":"Aivazian","year":"2021","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.nano.2025.102817_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202000100","article-title":"Engineered ovalbumin nanoparticles for cancer immunotherapy","volume":"3","author":"Habibi","year":"2020","journal-title":"Advanced Therapeutics"},{"issue":"11","key":"10.1016\/j.nano.2025.102817_bb0365","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/94.11.805","article-title":"Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?","volume":"94","author":"Parmiani","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nano.2025.102817_bb0370","series-title":"A Comprehensive Review on Pharmacokinetic Studies of Vaccines: Impact of Delivery Route, Carrier-and its Modulation on Immune Response","author":"Jha","year":"2023"},{"issue":"11","key":"10.1016\/j.nano.2025.102817_bb0375","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.tibtech.2021.02.004","article-title":"Towards in silico process modeling for vaccines","volume":"39","author":"Cardillo","year":"2021","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2025.102817_bb0380","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.addr.2021.03.015","article-title":"Immunocompetent cancer-on-chip models to assess immuno-oncology therapy","volume":"173","author":"Maulana","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102817_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.coche.2023.100998","article-title":"Accelerating vaccine manufacturing development through model-based approaches: current advances and future opportunities","volume":"43","author":"Ramin","year":"2024","journal-title":"Curr Opin Chem Eng"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:33:20Z","timestamp":1778618000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":77,"alternative-id":["S1549963425000176"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102817","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma immunotherapy by nanosphere-vaccine elicited CD4+ and CD8+ T-cell response for tumor regression","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102817"}}